1. Home
  2. BLFY vs FULC Comparison

BLFY vs FULC Comparison

Compare BLFY & FULC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Blue Foundry Bancorp

BLFY

Blue Foundry Bancorp

HOLD

Current Price

$12.54

Market Cap

185.3M

Sector

Finance

ML Signal

HOLD

Logo Fulcrum Therapeutics Inc.

FULC

Fulcrum Therapeutics Inc.

HOLD

Current Price

$12.93

Market Cap

468.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLFY
FULC
Founded
1939
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Commercial Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
185.3M
468.1M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
BLFY
FULC
Price
$12.54
$12.93
Analyst Decision
Hold
Buy
Analyst Count
1
8
Target Price
$10.00
$16.38
AVG Volume (30 Days)
290.5K
2.6M
Earning Date
01-28-2026
10-29-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$44,731,000.00
N/A
Revenue This Year
$19.85
N/A
Revenue Next Year
$20.18
N/A
P/E Ratio
N/A
N/A
Revenue Growth
11.52
2752.05
52 Week Low
$7.61
$2.32
52 Week High
$12.73
$15.74

Technical Indicators

Market Signals
Indicator
BLFY
FULC
Relative Strength Index (RSI) 83.06 61.65
Support Level $11.93 $12.56
Resistance Level $12.73 $15.32
Average True Range (ATR) 0.36 1.27
MACD 0.15 0.30
Stochastic Oscillator 93.62 60.90

Price Performance

Historical Comparison
BLFY
FULC

About BLFY Blue Foundry Bancorp

Blue Foundry Bancorp is a full-service bank. Its business consists of originating one-to-four-family residential, multi-family, and non-residential real estate mortgages, home equity loans and lines of credit, and commercial and industrial loans. It attracts retail deposits from the general public in the areas surrounding its banking offices, through its borrowers, and through its online presence, offering a wide variety of deposit products. The bank also invests in securities. Its revenues are derived from interest on loans and, to a lesser extent, interest on mortgage-backed and other investment securities. The company's sources of funds are deposits, principal, and interest payments on loans, securities, and borrowings from the Federal Home Loan Bank of New York.

About FULC Fulcrum Therapeutics Inc.

Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.

Share on Social Networks: